Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory Waldenstrom macroglobulinemia Meeting Abstract


Authors: Lewis, D. J.; Palomba, M. L.; Patel, M. R.; Eyre, T. A.; Jurczak, W.; Gastinne, T.; Ma, S.; Cohen, J. B.; Patel, K.; Brown, J. R.; Scarfò, L.; Munir, T.; Lech-Maranda, E.; Hoffmann, M. S.; Ujjani, C. S.; Fakhri, B.; Wang, M.; Izutsu, K.; Nagai, H.; Tam, C. S.; Seymour, J. F.; Rhodes, J. M.; Vose, J.; McKinney, M.; Gerson, J. N.; Barve, M. A.; Kuss, B.; Koh, Y.; Gao, W.; Ruppert, A. S.; Walgren, R. A.; Tsai, D. E.; Nair, B.; Bao, K.; Mato, A. R.; Cheah, C. Y.
Abstract Title: Efficacy of pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in relapsed/refractory Waldenstrom macroglobulinemia
Meeting Title: 63rd Annual Scientific Meeting of the British Society for Haematology
Journal Title: British Journal of Haematology
Volume: 201
Issue: Suppl. 1
Meeting Dates: 2023 Apr 23-25
Meeting Location: Birmingham, United Kingdom
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2023-04-01
Start Page: 109
End Page: 110
Language: English
ACCESSION: WOS:001049283000179
PROVIDER: wos
DOI: 10.1111/bjh.18720
Notes: Meeting Abstract: BSH23-PO82 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba
  2. Anthony R Mato
    235 Mato